AZ on Monday announced the opening of its new cell therapy manufacturing site in Rockville, Maryland. The $300 million facility will employ at least 150 workers and produce clinical and potential commercial CAR-T treatments. The facility is part of AZ’s commitment to invest $3.5 billion in the USA. Source: Fierce Pharma 6/5/2025